Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
FDA, Pfizer and hemophilia B
On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -0.61%) ...
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
Pfizer said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of ...
Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...
Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...
Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback